167 related articles for article (PubMed ID: 20139074)
1. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.
Imoto A; Okada M; Okazaki T; Kitasato H; Harigae H; Takahashi S
J Biol Chem; 2010 Apr; 285(14):10300-9. PubMed ID: 20139074
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of the metallothionein-1A promoter by PU.1 during differentiation of THP-1 cells.
Suzuki S; Nakano H; Takahashi S
Biochem Biophys Res Commun; 2013 Apr; 433(3):349-53. PubMed ID: 23501100
[TBL] [Abstract][Full Text] [Related]
3. Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.
Iseki Y; Nakahara M; Kubo M; Obata F; Harigae H; Takahashi S
Int J Mol Med; 2012 Feb; 29(2):319-23. PubMed ID: 22075620
[TBL] [Abstract][Full Text] [Related]
4. Identification of annexin 1 as a PU.1 target gene in leukemia cells.
Iseki Y; Imoto A; Okazaki T; Harigae H; Takahashi S
Leuk Res; 2009 Dec; 33(12):1658-63. PubMed ID: 19428102
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
[TBL] [Abstract][Full Text] [Related]
6. The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells.
Aoyama S; Nakano H; Danbara M; Higashihara M; Harigae H; Takahashi S
Biochem Biophys Res Commun; 2012 Apr; 420(4):775-81. PubMed ID: 22459451
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
[TBL] [Abstract][Full Text] [Related]
8. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
10. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
11. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
12. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.
Dluhosova M; Curik N; Vargova J; Jonasova A; Zikmund T; Stopka T
PLoS One; 2014; 9(2):e87448. PubMed ID: 24498324
[TBL] [Abstract][Full Text] [Related]
14. PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.
Burda P; Curik N; Kokavec J; Basova P; Mikulenkova D; Skoultchi AI; Zavadil J; Stopka T
Mol Cancer Res; 2009 Oct; 7(10):1693-703. PubMed ID: 19825991
[TBL] [Abstract][Full Text] [Related]
15. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Metallothionein-1G Accelerates G1/S Transition in the Growth Phase of Acute Promyelocytic Leukemia NB4 Cells.
Hirako N; Takahashi S
Ann Clin Lab Sci; 2021 Jan; 51(1):38-43. PubMed ID: 33653779
[TBL] [Abstract][Full Text] [Related]
17. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.
Qian M; Jin W; Zhu X; Jia X; Yang X; Du Y; Wang K; Zhang J
J Hematol Oncol; 2013 Apr; 6():25. PubMed ID: 23547873
[TBL] [Abstract][Full Text] [Related]
18. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic control of hematopoiesis: the PU.1 chromatin connection.
van Riel B; Rosenbauer F
Biol Chem; 2014 Nov; 395(11):1265-74. PubMed ID: 25205721
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
